tiprankstipranks
Trending News
More News >

Philina Lee Insider Profile

4 Followers
Philina Lee, Director at Fusion Pharmaceuticals, holds ― shares in Fusion Pharmaceuticals (Ticker: FUSN), holds 0.00 shares in Blueprint Medicines (Ticker: BPMC). Most recently, Philina Lee ― shares of Fusion Pharmaceuticals on ― for an estimated value of ―.
tipranks
Philina Lee

Philina Lee
Fusion Pharmaceuticals (FUSN)
Director

Ranked #92,062 out of 106,131 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

-37.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Philina Lee does not currently own shares as a corporate insider.
A breakdown of Philina Lee's holdings

Insider Roles

Philina Lee does not currently hold a role as a corporate insider.
Roles that Philina Lee holds in companies

Most Profitable Insider Trade

Stock:
Blueprint Medicines
(BPMC)
Rating:Informative Sell
Date:Mar 11, 2024 - Mar 11, 2025
Return:+1.90%
The most profitable trade made by Philina Lee

Philina Lee's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
FUSN
Fusion Pharmaceuticals
BPMC
Blueprint Medicines
Jul 21, 2025
Uninformative Buy
$0.00
List of latest transactions for each holding click on a transaction to see Philina Lee's performance on stock

Philina Lee insider profile FAQ

What is the percentage of profitable transactions made by Philina Lee?
The percentage of profitable transactions made by Philina Lee is 50%.
    What is the average return per transaction made by Philina Lee?
    The average return per transaction made by Philina Lee is -37.40%.
      What stocks does Philina Lee hold?
      Philina Lee holds: FUSN, BPMC stocks.
        What was Philina Lee’s latest transaction?
        Philina Lee latest transaction was an Uninformative Buy of ―.
          What was Philina Lee's most profitable transaction?
          Philina Lee’s most profitable transaction was an Informative Sell of BPMC stock on March 11, 2024. The return on the trade was 1.90%.
            What is Philina Lee's role in Fusion Pharmaceuticals?
            Philina Lee's role in Fusion Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.